RxDoctor Payments Data
★ My doctorsLook up a doctor →

Michael Daunov

Cleveland, OHNPI 1841796372

Payments from drug & device makers

$1,902in general payments, 2019–2025

Across 84 payments — averaging $22.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi$265
  • Pfizer$157
  • Novartis$154
  • Takeda Pharmaceuticals U.S.A., Inc.$153
  • AstraZeneca$133
  • Blueprint Medicines Corporation$114
  • plus $927 from 21 others

What the payments were for

  • Food & beverage$1,902100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Sanofi8$265
Pfizer8$157
Novartis8$154
Takeda Pharmaceuticals U.S.A., Inc.6$153
AstraZeneca(2 entities)6$133
Blueprint Medicines Corporation4$114
Merck5$91
Daiichi Sankyo Inc.3$83
Incyte Corporation4$81
Eisai Inc.4$78
Beone Medicines USA, Inc.2$65
ADC Therapeutics America, Inc.3$58
Bristol Myers Squibb3$52
Seagen Inc.3$51
Genmab U.S., Inc.2$46
AbbVie2$41
Jazz Pharmaceuticals Inc.2$39
Gilead(2 entities)2$36
Astellas Pharma US Inc1$31
Lilly USA, LLC1$27
Regeneron Healthcare Solutions, Inc.1$26
Agios Pharmaceuticals, Inc.1$25
Amgen1$24
Sobi, Inc1$20
Array Biopharma Inc1$20
Beigene USA, Inc.1$18
Springworks Therapeutics, Inc.1$14

Where these figures come from

Is this you, or does something look wrong? →